INTRODUCTION
Vascular tumors of the breast are uncommon neoplasms which can be benign, premalignant, or malignant. Angiomatosis of the breast is a rare condition that can simulate carcinoma and mislead specialist breast imagers regardless of experience. Angiomatosis most commonly appears in isolation, may be large, and, due to shared imaging features, needs to be differentiated from angiosarcoma. [1] We report a very unique and complex case of a patient with coexisting recurrent breast angiomatosis and cerebellar hemangioblastoma in whom no underlying phakomatosis was identified.
e clinical presentation, physical findings, mammography, ultrasonography, and neuroradiology are presented and discussed, in combination with a review of the literature with regard to this extremely rare combination of pathologies. 
CASE REPORT
In 2015, a 47-year-old female was referred to the triple breast assessment clinic with a left-sided breast lump. She had no history of breast pathology. Physical examination revealed a painless, palpable mass. A subsequent ultrasound of the whole left breast was performed which demonstrated a solitary hypoechoic, irregular mass measuring approximately 2 cm located at 2 o' clock in the upper outer quadrant. ere was no associated axillary lymphadenopathy.
Bilateral mammography was performed demonstrating an irregular suspicious mass with features suggestive of malignancy, thus assigned BI-RADS 5 [ Figure 1 ].
After administration of local anesthetic, ultrasound-guided core biopsies using a 14-Gauge needle were performed, and multiple samples sent for histopathologic examination. Histopathology revealed a diagnosis of breast angiomatosis with no evidence of malignancy or atypia.
Given the tendency of these rare tumors to recur, wide local excision with clear margins was performed. e mass was clearly palpable and thus there was no need to perform wire localization. Routine follow-up was advised.
ree years later, the patient re-presented to the triple breast assessment clinic with suspected local recurrence. e mammographic and sonographic features were suspicious, again showing a similar irregular lesion, which was indistinguishable from cancer [ Figures 2 and 3 ]. e initial vascular lesion recurred despite the previously noted clear margins, and the complete excision was again recommended.
us, it is important to highlight the risk of recurrence with regard to this uncommon entity.
Seven years before her initial breast presentation, she had been referred to the neurology department with nausea, dizziness, and unsteady gait. Neuroradiology demonstrated typical appearances consistent with right-sided cerebellar hemangioblastoma on both computed tomography and postcontrast magnetic resonance imaging (MRI) [ Figure 4 ].
MRI of the brain revealed cerebellar tumor consistent of a large cystic component and a small associated enhancing mural nodule on T1 post-gadolinium sequence. e cystic component remained unchanged on both pre-and postcontrast images. ere was associated subsequent hydrocephalus. No other findings or associated symptoms to suggest phakomatosis were evident. After successful neurosurgery, the patient was discharged with no immediate complications.
DISCUSSION
In general, angiomatosis of the breast is extremely rare with few cases reported in the literature. [2] ese vascular tumors may demonstrate as palpable masses on physical examination. [3] e possible age of presentation is between 20 and 60 years. [4] It is important to note that this unusual entity may appear in both sexes, with a female predominance. [4] Angiomatosis may recur after local excision and thus complete excision with clear margins is recommended. [2] Mastectomy is a consideration for diffuse disease that cannot be fully treated with breast-conserving surgery. [1] Hemangioblastoma is a benign vascular neoplasm mostly occurring in the cerebellum, which may be related to von Hippel-Lindau disease or appear in isolation. [5] Juvenile pilocytic astrocytoma is the main differential; however, the latter occurs in a younger group of patients. [6, 7] Given the vascular nature of the presented coexisting tumors, both cerebellar hemangioblastoma and the breast angiomatosis, an underlying phakomatosis with regards to von Hippel-Lindau syndrome was a consideration. is has not been confirmed in the subsequent multidisciplinary diagnostic process, and the groups suggested no overt connection between the lesions. us, it remains uncertain if there is a causal relationship between these symptomatic presentations with vascular lesions of the central nervous system and the breast or if it is purely coincidental. e rarity of angiomatosis means research has been limited. [8] To the best of our knowledge, there is no overt association between angiomatosis of the breast and von Hippel-Lindau disease. [9] However, more cases need to be reported to establish the significance of this combination and to evaluate if there is a predisposing genetic mutation or connection.
CONCLUSIONS
Angiomatosis of the breast is a very unusual vascular tumor, and only limited cases have been reported. Moreover, cerebellar hemangioblastoma and breast angiomatosis is a very exceptional combination and research needs to be performed to establish the exact significance of this coexistence. It remains unknown if there is an underlying genetic abnormality that could contribute to the formation of both vascular tumors in this particular case.
No specific mammographic or sonographic features were visualized to support the diagnostic breast imaging process. Even armed with the broad knowledge of potential vascular breast cancer mimickers, it is not possible to make such a diagnosis based on imaging alone. us, histopathological confirmation is required. e mammary angiomatosis can be fully cleared with breast-conserving surgery in most cases, and the overall prognosis is excellent.
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